Calcium, Iron, and Levothyroxine: The 4-Hour Rule

Calcium and iron supplements bind levothyroxine in the stomach, forming insoluble complexes that block absorption. Calcium carbonate cuts T4 uptake by about 20-30%, and ferrous sulfate raised TSH from 1.6 to 5.4 mU/L in 79% of hypothyroid patients in a 12-week trial. The American Thyroid Association recommends a 4-hour gap.

Why the calcium iron levothyroxine timing rule matters

If you take a daily multivitamin, a calcium chew at breakfast, or an iron tablet for low ferritin, you may be quietly cutting your thyroid dose by a third without knowing it [C1, C3]. Most people on levothyroxine learn the empty-stomach rule on day one, but the 4-hour rule for calcium, iron, and antacids is different — and far less well known. The mechanism is chemical, not behavioral: the minerals bind directly to the drug in your gut, before it ever reaches the bloodstream [C1, C5]. This article walks through the studies that established the rule and what it means for your morning routine.

What the research actually shows

Three landmark studies anchor the evidence. In Singh, Singh & Hershman 2000, a prospective cohort of 20 hypothyroid adults showed that co-ingesting 1,200 mg of elemental calcium as calcium carbonate raised mean TSH from 1.6 to 2.7 mIU/L over three months and pushed 20% of patients above the normal TSH range [C1]. Free T4 and total T4 both fell during the calcium period and recovered after it stopped [C1]. In vitro work in the same study showed that at gastric pH 2.0, only 52% of T4 stayed in solution when mixed with calcium carbonate, versus near-complete recovery at neutral pH — direct evidence that the drug adsorbs to calcium in the acidic stomach [C1].

Zamfirescu & Carlson 2011 then tested whether the form of calcium mattered. In a single-dose crossover in eight healthy adults, calcium carbonate, calcium citrate, and calcium acetate each reduced levothyroxine absorption by roughly 20-25% [C2]. The popular nutrition-blog claim that "calcium citrate is the safe form" does not survive this study [C2].

Iron is more dramatic. Campbell et al. 1992 gave 14 hypothyroid adults 300 mg of ferrous sulfate alongside their thyroxine for 12 weeks; mean TSH rose from 1.6 ± 0.4 to 5.4 ± 2.8 mU/L, 11 of 14 patients (79%) had biochemical worsening, and 9 of 14 developed clinical hypothyroid signs and symptoms [C3]. When iron and thyroxine were mixed in vitro, a poorly soluble purple complex formed, indicating direct iron-thyroxine binding [C3]. A 1997 case report reinforced the real-world picture: a patient became hypothyroid on ferrous sulfate, required a higher levothyroxine dose, then swung hyperthyroid when the iron was stopped [C4].

Antacids work the same way. Liel, Sperber & Shany 1994 found that aluminum hydroxide raised mean TSH from 2.62 ± 0.8 to 7.19 ± 1.3 mU/L during co-ingestion periods, with in vitro data showing nonspecific T4 adsorption to the antacid surface [C5]. Three subsequent systematic reviews — Wiesner 2021, Liu 2023 — have replicated and consolidated these findings [C7, C9].

Where the evidence is weaker

Not everyone is affected equally. Singh 2000 saw 20% of patients exceed the normal TSH range; Campbell 1992 saw 79% with biochemical worsening but only 64% with symptoms [C1, C3]. You cannot tell in advance which group you fall into. Formulation matters too: liquid and soft-gel levothyroxine appear to attenuate the calcium and iron interaction seen with tablets [C8]. That is real but does not generalize to the standard tablet most patients receive [C8].

The 4-hour interval itself is conventional, not experimentally optimized. The 2014 American Thyroid Association guideline explicitly notes that "a 4-hour separation is traditional, but untested" — meaning the direction (separate them) is well-supported, while the exact number is pragmatic [C6]. A 2023 systematic review put the range at 2-8 hours [C9]. Foundational human evidence is also specifically with ferrous sulfate; ferrous gluconate, ferrous fumarate, polysaccharide-iron, and ferric maltol have not been characterized as rigorously, though the binding mechanism is plausible across iron salts [C3, C4].

Practical guidelines

1. Separate calcium, iron, and aluminum/magnesium antacids from your levothyroxine by 4 hours. This applies to standalone supplements (calcium chews, ferrous sulfate, Tums, Maalox, Mylanta) and to multivitamins or prenatals that contain calcium or iron [C1, C3, C5, C6].
2. All calcium forms behave the same way. Carbonate, citrate, and acetate each cut absorption by about 20-25% — there is no exempt form [C2].
3. Apply the same 4-hour rule to soy protein supplements and dietary fiber supplements like psyllium. Soy raised TSH substantially in infants on soy formula, and psyllium reduced absorption by about 9% in healthy volunteers [C7].
4. If your morning is crowded, consider bedtime dosing. Many people who take iron or calcium with breakfast find it easier to move levothyroxine to bedtime, on an empty stomach at least 3-4 hours after the last meal — discuss this option with your healthcare provider before switching [C6].
5. Tell your healthcare provider when you start or stop iron or calcium. Adding iron may require a higher levothyroxine dose; stopping it may require a lower one [C4].

Frequently asked questions

Does calcium in food count toward the 4-hour rule? No. The 4-hour rule applies to supplements and antacids, where the calcium dose is concentrated enough to bind a meaningful fraction of the drug [C1, C2]. Dietary calcium from a normal meal is covered by the standard empty-stomach window covered in the empty-stomach guide.

Is calcium citrate safer than calcium carbonate with levothyroxine? No. A crossover study tested calcium carbonate, citrate, and acetate head-to-head and found all three reduced levothyroxine absorption by about 20-25% [C2]. Form does not exempt you from the 4-hour rule.

What about the iron in my multivitamin or prenatal? The same 4-hour rule applies. Most multivitamins and prenatals contain both iron and calcium, the two best-documented offenders [C1, C3, C7]. Spacing the multivitamin from your thyroid pill is the simplest fix.

Does this rule apply to liquid or soft-gel levothyroxine? A 2023 systematic review found liquid L-T4 appears refractory to iron interference, but the underlying evidence base is small and observational [C8]. The standard tablet, which most patients receive, still requires the 4-hour separation [C8].

Bottom line

Calcium, iron, and aluminum/magnesium antacids form chemical complexes with levothyroxine in the stomach and can cut absorption by 20-30% — enough to push TSH out of range in a meaningful share of patients [C1, C2, C3, C5]. The fix is mechanical: leave 4 hours between your thyroid pill and any of these supplements, multivitamins included [C6]. This is separate from the 60-minute rule for coffee and food — different mechanism, different window.

Sources

1. [C1] Singh N, Singh PN, Hershman JM (2000). Effect of Calcium Carbonate on the Absorption of Levothyroxine. JAMA 283(21):2822-2825. PubMed: 10838651
2. [C2] Zamfirescu I, Carlson HE (2011). Absorption of Levothyroxine When Coadministered with Various Calcium Formulations. Thyroid 21(5):483-486. PubMed: 21595516
3. [C3] Campbell NRC, Hasinoff BB, Stalts H, Rao B, Wong NCW (1992). Ferrous Sulfate Reduces Thyroxine Efficacy in Patients with Hypothyroidism. Annals of Internal Medicine 117(12):1010-1013. PubMed: 1443969
4. [C4] Shakir KMM, Chute JP, Aprill BS, Lazarus AA (1997). Ferrous Sulfate-Induced Increase in Requirement for Thyroxine. Southern Medical Journal 90(6):637-639. PubMed: 9191742
5. [C5] Liel Y, Sperber AD, Shany S (1994). Nonspecific Intestinal Adsorption of Levothyroxine by Aluminum Hydroxide. American Journal of Medicine 97(4):363-365. PubMed: 7942938
6. [C6] Jonklaas J, Bianco AC, Bauer AJ, et al. (2014). Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force. Thyroid 24(12):1670-1751. PubMed: 25266247
7. [C7] Wiesner A, Gajewska D, Paśko P (2021). Levothyroxine Interactions with Food and Dietary Supplements: A Systematic Review. Pharmaceuticals 14(3):206. PubMed: 33801406
8. [C8] Maltese et al. (2023). Simultaneous Intake of Liquid L-T4 Formulation and Iron Salt: Fact or Fiction? Acta Endocrinologica (Bucharest). PMC10439335
9. [C9] Liu et al. (2023). Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review. Therapeutics and Clinical Risk Management. PMC10295503

---

For educational purposes only. Not medical advice. Always consult your healthcare provider.